Researchers have uncovered answers that provide the detail to explain two specific DNA repair processes that have long been in question. Researchers from the University of Birmingham have ...

Pembrolizumab (Keytruda), an anti-PD-1 antibody, cleared minimal residual disease and protected against recurrence in patients with DNA mismatch repair-deficient (dMMR) early-stage solid cancers ...

Dostarlimab effectively eliminates the need for surgery in patients with advanced mismatch repair–deficient ... dMMR refers to a malfunction in the DNA repair mechanism, which causes errors ...

Researchers from the University of Birmingham have uncovered answers that provide the detail to explain two specific DNA repair processes that have long been in question. The publication of two ...

This decision came after it was contended that the DNA sample of the rape survivor did not match his, and questions were raised about the girl's age. In Feb, a court in Dhoraji town of Rajkot ...

CHICAGO – PD-1 blockade with dostarlimab (Jemperli) induced complete tumor clearance and resolved the need for surgery in patients with locally advanced, mismatch repair-deficient (dMMR ...

[1] Lynch syndrome is the most common hereditary condition of CRC caused by MSI-inherited mutations in genes responsible for DNA mismatch repair. It significantly increases the risk of developing ...